Roughly 25 to 40% of the weight people lose on a GLP-1 can come from lean mass if nothing else changes. That number sounds alarming, and it should, but it’s not destiny. It’s a signal that fast weight loss without a plan for the rest of your body will cost you muscle, strength, and metabolic rate you’d rather keep.
The fix isn’t complicated. It’s protein, resistance training, body composition tracking, and in some cases supporting peptides. This post breaks down what the research shows, what the four levers look like in practice, and how Defiant builds them into every GLP-1 protocol.
Why GLP-1s Can Cost You Muscle
GLP-1 medications work in part by reducing appetite. That’s the point. But when calorie intake drops fast and protein intake drops with it, the body breaks down lean tissue alongside fat to cover the gap.
A 2021 analysis of the STEP-1 trial data found that participants on semaglutide lost meaningful amounts of fat-free mass, the category that includes muscle, even though most of the total weight loss was fat. The proportion of weight lost as lean mass tracked with how aggressively people lost weight overall.
This isn’t unique to GLP-1s. It’s what happens with any rapid weight loss. The difference is that GLP-1s make rapid loss easy enough that people don’t always realize what they’re losing.
Three things drive lean mass loss on a GLP-1:
- Lower total calorie intake. Less food in means less raw material for muscle protein synthesis.
- Lower protein intake specifically. Appetite suppression hits protein-heavy meals hardest for many people. Chicken and steak feel like work.
- Reduced training stimulus. Lower energy and reduced gym frequency are common in the first few months.
None of these are reasons to skip a GLP-1. They’re reasons to plan around it.
The Four-Lever Protocol
Protein Target: 0.7 to 1.0 g per lb of goal weight
This is the single most important lever. Research on weight loss in older adults and athletes consistently shows that higher protein intake during a calorie deficit preserves lean mass at much higher rates than standard intake.
If your goal weight is 160 lbs, that’s roughly 110 to 160 grams of protein per day. On a GLP-1, hitting that number is harder than it sounds because you’re less hungry. Strategies that work:
- Front-load protein at breakfast (30+ grams)
- Use a whey or collagen shake when food feels unappealing
- Plan protein first, build the rest of the meal around it
Resistance Training: 2 to 4 Sessions per Week
You don’t need to become a powerlifter. You need a stimulus that tells your body to hold onto muscle while you’re in a deficit.
Two to four sessions per week of full-body resistance training — barbell, dumbbell, or machine-based — is enough for most people. The pattern that works best during weight loss is fewer reps with heavier loads, not light-weight high-rep “toning” work. Heavy stimulus protects muscle in a deficit. Endurance work doesn’t.
Body Composition Tracking, Not Just the Scale
The bathroom scale can’t tell you whether you lost five pounds of fat or three pounds of fat and two pounds of muscle. A 3D body composition scan can.
Defiant runs a baseline scan on every weight loss patient and a follow-up scan monthly. The data tells you whether the protocol is working, and if lean mass is dropping faster than it should, the plan changes before you lose ground you can’t easily get back.
Supporting Peptides Where Appropriate
Several peptides used in clinical practice may support lean mass retention during weight loss. They’re not magic, they’re not required, and they’re not for everyone. For the right patient, they can be part of the protocol.
- Ipamorelin and CJC-1295 — growth hormone secretagogues that may support recovery and lean mass signaling.
- BPC-157 — may support tendon and joint recovery, which matters because the limiting factor on resistance training is often joint pain, not motivation.
These are prescribed only after bloodwork and a provider consult. Research on their use specifically alongside GLP-1s is early, and we don’t promise specific outcomes.
How Defiant Builds This In
Every Defiant weight loss program starts with three things before anyone writes a prescription:
- Bloodwork to confirm candidacy
- A 3D body composition scan as a baseline
- A provider consult to set protein, training, and tracking targets
Body comp scans repeat monthly. Weekly nurse check-ins flag anyone whose lean mass is trending the wrong direction. Custom dose adjustments and supporting peptides get added when the data says they should, not on a schedule, and not for everyone.
For patients who want a training stimulus but don’t have a program they trust, Defiant now offers personal training in-clinic. Sessions are built around the resistance-training principles above and adjusted as your body composition data comes in. You don’t have to use it. But if the gap between knowing what to do and actually doing it is the thing standing between you and the result, that gap is now closed.
This is the difference between a GLP-1 prescription and a GLP-1 protocol. The prescription is the easy part. The protocol is what keeps the weight off and the muscle on.
- 25 to 40% of weight lost on a GLP-1 can come from lean mass without a deliberate plan to protect it.
- Protein at 0.7 to 1.0 grams per pound of goal body weight is the single most important lever.
- Two to four resistance training sessions per week, heavy enough to be hard for 6 to 10 reps, protects muscle in a deficit. Cardio does not.
- A 3D body composition scan tells you what the bathroom scale can’t — whether you’re losing fat or muscle.
- Supporting peptides may help in the right patient but are protocol-specific, not default.
Common Questions
Build a GLP-1 protocol that protects what you’ve built.
Every Defiant weight loss program includes bloodwork, a 3D body composition scan, weekly check-ins, and a provider who actually looks at your numbers. Free consultation.
Keep Reading
Last updated May 17, 2026.
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002. NEJM
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216. NEJM
- Sargeant JA, Henson J, King JA, et al. A Review of the Effects of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lean Body Mass in Humans. Endocrinol Metab. 2019;34(3):247-262. PubMed
- Cava E, Yeat NC, Mittendorfer B. Preserving Healthy Muscle during Weight Loss. Adv Nutr. 2017;8(3):511-519. PubMed